MacFarlane 4th, A.W., Yeung, H.-M., Alpaugh, R.K., Dulaimi, E., Engstrom, P.F., Dasari, A., Campbell, K.S.*, and Vijayvergia, N.* (2020) Impacts of Pembrolizumab Therapy on T and NK cells in Patients with High-grade Neuroendocrine Neoplasms. Cancer Immunol. Immunother., in press. *Corresponding authors
Francescone, R., Vendramini-Costa, D.B., Franco-Barraza, J., Wagner, J., Muir, A., Lau, A.N., Gabitova, L., Pazina, T., Gupta, S., Luong, T., Shah, N., Rollins, D., Malik, R., Thapa, R., Restifo, D., Zhou, Y., Cai, K.Q., Hensley, H.H., Tan, Y., Kruger, W.D., Devarajan, K., Balachandran, S., Klein-Szanto, A.J., El-Deiry, W.S., Vander Heiden, M.G., Peri, S., Campbell, K.S., Astsaturov, I., and Cukierman, E. (2020) Netrin G1/NGL-1 axis promotes pancreatic tumorigenesis through cancer associated fibroblast driven nutritional support and immunosuppression. Cancer Discovery, in press.
Fernandez, S.V., MacFarlane IV, A.W., Jillab, M., Arisi, M.F., Yearley, J., Annamalai, L., Alpaugh, R.K., Cristofanilli, M., and Campbell, K.S. (2020) Immune phenotype of patients with stage IV metastatic inflammatory breast cancer. Breast Cancer Res., 22:134.
Cheng, H., Schwell, V., Curtis, B.R., Fazlieva, R., Roder, H., and Campbell, K.S. (2019) Conformational Changes in the Cytoplasmic Region of KIR3DL1 upon Interaction with SHP-2. Structure, 27:639-650. PMCID: 6447435.
Kundu, K., Ghosh, S., Sarkar, R., Edri, A., Brusilovsky, M., Gershoni-Yahalom, O., Yossef, R., Shemesh, A., Soria, J.C., Lazar, V., Joshua, B.Z., Campbell, K.S., Elkabets, M., and Porgador, A. (2019) Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA. Cancer Immunol. Res., 7:1120-1134. PMCID: 7233522.
Pazina, T., James, A.M., Colby, K.B., Yang, Y., Gale, A., Jhatakia, A., Kearney, A., Bezman, N.A., Graziano, R.F., Robbins, M.D., Cohen, A.D., and Campbell, K.S. (2019) Enhanced SLAMF7 homotypic interactions by elotuzumab improves NK cell killing of multiple myeloma. Cancer Immunol. Res., 7:1633-1646. PMCID: 6774869.
Wagner, J., Kline, C.L., Zhou, L.L., Campbell, K.S., MacFarlane 4th, A.W., Olszanski, A.J., Cai, K.Q., Hensley, H.H., Ross, E.A., Ralff, M.D., Zloza, A., Chesson, C.B., Newman, J.H., Kaufman, H., Bertino, J., Stein, M., El-Deiry, W.S. (2018) Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment. Journal of Clinical Investigation, 128(6):2325-38, 2018. PMCID: 5983321.
MacFarlane 4th, A.W., Jillab, M., Smith, M.R., Alpaugh, R.K., Cole, M., Litwin, S., Millenson, M.M., Al-Saleem, T., Cohen, A.D.,* and Campbell, K.S.* (2017) NK Cell Dysfunction in Chronic Lymphocytic Leukemia is Associated with Loss of the Mature Cells Expressing Inhibitory Killer Cell Ig-like Receptors, Oncoimmunology, 6:e1330235. PMCID: 5543845. *Corresponding authors. tandfonline.com
Pazina, T., James, A.M., MacFarlane 4th, A.W., Bezman, N.A., Henning, K.A., Bee, C., Graziano, R.F., Robbins, M.D., Cohen, A.D. *, and Campbell, K.S. * (2017) The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and –independent mechanisms, Oncoimmunology, 6:e1339853. PMCID: 5599094 tandfonline.com
Davis, Z.B., Cogswell, A., Hamish, S., Mertsching, A., Boucau, J., Wambua, D., Le Gall, S., Planelles, V., Campbell, K.S., and Barker, E. (2016) A conserved HIV-1-derived peptide presented by HLA-E renders infected T-cells highly susceptible to attack by NKG2A/CD94-bearing natural killer cells. PLoS Pathog, 12:e1005421. PMCID: 4735451
Shemesh, A., Brusilovsky, M., Hadad, U., Teltsh, O., Edri, A., Rubin, E., Campbell, K.S., Rosental, B., and Porgador, A. (2016) Survival in acute myeloid leukemia is associated with NKp44 splice variants. Oncotarget, 7:32933-32945. PMCID: 5078064.
Steblyanko, M., Anikeeva, N., Campbell, K.S., Keen, J.H., and Sykulev, Y. (2015) Integrins Influence the Size and Dynamics of Signaling Microclusters in a Pyk2-dependent Manner. J. Biol. Chem., 290:11833-11842. PMCID: 4424324.
MacFarlane 4th, A.W., Jillab, M., Plimack, E.R., Hudes, G.R., Uzzo, R.G., Litwin, S., Dulaimi, E., Al-Saleem, T., and Campbell, K.S. (2014) PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection. Cancer Immunol. Res., 2:320-331. PMCID: 4007343.
Purdy, A.K., Alvarez-Arias, D.A., Oshinsky, J., James, A.M., Serebriiskii, I., and Campbell, K.S. (2014) The AP-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor (KIR) in human NK cells. J. Immunol., 193:4675-4683. PMCID: 4269369.
Brusilovsky, M., Cordoba, M., Rosental, B., Hershkovitz, O., Andrake, M.D., Pecherskaya, A., Einarson, M.B., Zhou, Y., Braiman, A., Campbell, K.S., and Porgador, A. (2013) Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses. J. Immunol., 191:5256-5267. PMCID: 3836631.